NASDAQ:ABEO

Abeona Therapeutics Stock Predictions

etoro logo Buy ABEO
*Your capital is at risk
$5.67
-0.0200 (-0.351%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

ABEO Prediction Chart

ABEO Predictions History

Latest community submissions for ABEO.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 30, 2025 $5.21 -1.78% $6.56 X 79.35% 0
Apr 30, 2025 Bullish $6.56 V 1
Apr 29, 2025 $5.21 -2.66% $5.30 V 98.25% 1
Apr 29, 2025 $5.26 -1.67% $5.30 V 99.26% 4
Apr 29, 2025 Bullish $5.30 X 0
Mar 28, 2025 Bullish $4.97 X 0
Feb 18, 2025 $5.92 -1.62% $5.85 V 98.76% 2
Feb 18, 2025 $5.96 -1.01% $5.85 V 98.14% 1
Feb 18, 2025 Bearish $5.85 V 1
Oct 23, 2023 $4.25 +2.63% $3.99 X 93.51% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABEO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABEONA THERAPEUTICS INC.
Abeona Therapeutics
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE